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Abstract  
One of the main aims of bone tissue engineering is to produce three-dimensional soft bone 
tissue constructs of acceptable clinical size and shape in bioreactors. The tissue constructs 55 
have been proposed as possible replacements for diseased or dysfunctional bones in the 
human body through surgical transplantations. However, because of certain restrictions to the 
design and operation of the bioreactors, the size of the tissue constructs attained are currently 
below clinical standards. We believe that understanding the fluid flow and nutrient transport 
behaviour in the bioreactors is critical in achieving clinically viable constructs. Nevertheless, 60 
characterization of transport behaviour in these bioreactors is not trivial. As they are very 
small in size and operate under stringent conditions, in-situ measurements of nutrients are 
almost impossible. This issue has been somewhat resolved using computational modelling in 
previous studies. However, there is still a lack of certainty on the suitability of bioreactors. To 
address this issue we systematically compare the suitability of three bioreactors for growing 65 
bone tissues using mathematical modelling tools. We show how nutrient transport may be 
improved in these bioreactors by varying the operating conditions and suggest which 
bioreactor may be best suited for operating at high cell densities in order to achieve soft bone 
tissues of clinical size. The governing equations defined in our mathematical frameworks are 
solved through finite element method. The results show that the hollow fiber membrane 70 
bioreactor (HFMB) is able to maintain higher nutrient concentration during operation at high 
cell densities compared to the other two bioreactors, namely suspended tube and confined 
profusion type bioreactor. Our results show that by varying the operating conditions nutrient 
transport may be enhanced and the nutrient gradient can be substantially reduced. These are 
consistent with previous claims suggesting that the HFMB is suited for bone tissue growth at 75 
high cell densities. 
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1. Introduction 
The worldwide need for bone replacements is currently critical. This is because the natural 
substitutes for dysfunctional or damaged bones are limited compared to the number of 85 
medical cases that seek bone replacements. Furthermore, the current alternatives of 
autografting, allografting or inserting man-made materials are associated with many problems 
and may need medical attention after some time (Abdullah and Das, 2007; Ye et al., 2006; 
Vance et al. 2005; Fleming et al., 2000; Lanza et al., 1997; Yaszemski et al., 1996). Bone 
tissue engineering (BTE) promises a new route towards repair, restoration and regeneration of 90 
dysfunctional or impaired bones (Hollinger et al., 2005; Fleming et al., 2000; Lanza et al., 
1997). BTE protocols allow bone tissues to be grown in bioreactors, which promise to 
provide natural and inexhaustible supply of replacements for damaged bones. Excellent 
reviews on BTE can be found in the literature (e.g., Abdullah et al., 2006; Chong and Chang, 
2006; Nerem, 2006; Ye et al., 2006, 2004; Cortesini, 2005; Meyer et al., 2004a,b; Cancedda 95 
et al., 2003; Rose and Oreffo, 2002; Lanza et al., 1997). It is clear from these literatures that 
efforts have been proven successful for artificial bone tissue growth in laboratories. However, 
attaining constructs of clinical size is still a problem. Current bone tissue constructs are less 
than 0.5mm thick, which is still far from general clinical need of 2-5mm (Ye et al., 2006; 
Martin and Vermette, 2005; Freed and Vunjak-Novakovic, 1998).  100 
 
Please note that bone tissues, being mammalian tissues, rank among the most difficult tissues 
to grow under in vitro reactor conditions. This is because these tissues have critical nutrient 
needs, are sensitive to wastes of metabolic reactions and are highly fragile to shear stresses 
(Freshney, 2000; Smalt et al., 1997; Hillsley and Frangos, 1994). Hence, the bioreactors for 105 
BTE applications are expected to provide (i) physical support and protection to the tissues 
from forces acting on them and (ii) excellent mass transport for nutrients and wastes. This is 
especially so in case for growing bone tissues as bone cells may be found situated deep in the 
mineralized bone matrix. In the human body, ample nutrient distribution is achieved by 
having a complex network of blood vessels that penetrates through the mineralized bone 110 
matrix. Without these blood vessels, sufficient nutrient supply poses a huge challenge (Ye et 
al., 2006, 2004; Martin and Vermette, 2005). 
 
In addressing these challenges in artificial conditions, bioreactor designs have evolved 
significantly so that high nutrient concentrations can be maintained during their operation. 115 
Thus, many types of bioreactors have been introduced for growing bone tissues (Martin and 
Vermette, 2005; Wiesmann et al., 2004). It emerges from the review of these work that there 
are three main types of bioreactors which could be used for BTE applications. The first, 
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simplest and most widely used bioreactor are based on culture dishes and flasks (Martin and 
Vermette, 2005; Wiedmann-Al-Ahmad et al., 2002). They are easy to handle and fabricate 120 
and, cheaper compared to other types of bioreactors. A sample reactor that falls in this 
category is the suspended tube bioreactor (STB). As depicted in Figure 1, the STB is a batch 
process with cells seeded on a scaffold construct in the reactor flask which is submerged in a 
nutrient rich medium. In general, these bioreactors have high nutrient limitations and are 
unable to produce 3-D bone constructs. Furthermore, for large sized cell-filled porous 125 
scaffolds, high concentration of nutrient in the surrounding media coupled with poor transport 
mechanisms will create a severe nutrient gradient. As a result, cells inside the porous scaffold 
migrate (e.g., chemotaxis) to regions where nutrient concentration are higher. This creates a 
problem of inhomogeneous spatial distribution of cells in the extracapillary space (ECS) 
(Sengers et al., 2007). Sizeable 3-D bone tissue constructs of clinical value cannot be 130 
achieved this way. Although apparently that is the claim, no specific studies were made to 
compare the performance of the culture dishes and flasks (e.g., STB) at high cell densities to 
other bioreactors for BTE. Being the most primitive, simple and most widely used type of 
bioreactor, comparison between these and other type of bioreactors warrants some interest. 
This may include questions such as how mass transport can be improved in different 135 
bioreactors from a system which relies truly by diffusion alone, and with addition of 
perfusion. 
 
Since batch systems are not very effective for growing 3D bone tissues with high cell 
densities, a number of perfused bioreactors have been designed. These bioreactors operate 140 
with less need of manual handling as nutrient media can be pumped in and out of the systems. 
An example of a perfused bioreactor is the confined perfusion bioreactor (CPB), as shown in 
Figure 2. Further technical improvements in the area of in vitro bone tissue engineering have 
led to the development of more sophisticated bioreactor systems. Bioreactors for bone tissue 
growth promise now to mimic the physical conditions in the human body (Abdullah et al., 145 
2006; Ye et al., 2006) and bone morphology (Wiesmann et al., 2004, 1997). One example of 
such a bioreactor is the hollow fiber membrane bioreactor (HFMB). The HFMB consists of a 
hollow fiber (HF) bundle contained in an external housing. The cells are cultured in the ECS. 
A porous scaffold is placed in the ECS where cells attach to and proliferate. Nutrients are 
supplied by flowing media through the fiber lumen, which allow nutrient diffusion to the ECS 150 
across the fiber membranes. It has been claimed that the HFMB design offers better mass 
transfer behaviour as the HFs enable nutrients to be supplied to the centre of the bone tissues, 
mimicking the in-vivo blood vessels in human bones (Abdullah and Das, 2007; Das, 2007;  
Ye et al., 2006, 2004; Martin and Vermette, 2005). This promises to minimize mass transfer 
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limitations and enhance the possibility of growing thick bone tissue (3D). Figure 3 shows a 155 
single HF, depicted as a Krogh cylinder in the HFMB. 
Other perfused culture systems have also been documented, including spinner flasks (Gooch 
et al., 2001; Carrier et al., 1999; Vunjak-Novakovic et al., 1998) and rotary vessels (Chen and 
Hu, 2006; Detamore and Athanasiou, 2005; Qiu et al., 1999). The limitation with both of 
these systems is that mixing at the surface of the scaffolds may not be sufficient to deliver the 160 
necessary nutrients to the interior of the scaffold. Although attempts are made for bone tissue 
growth and regeneration (Chen and Hu, 2006; Detamore and Athanasiou 2005), the spinner 
flasks are usually operated at low cell numbers due to tedious needs in handling and poor 
mass transport (Goldstein et al., 2001). Furthermore, Freed and Vunjak-Novakovic (1995) 
reported that spinner flasks may not be optimal because the turbulent flow and the associated 165 
higher shear stress induce the formation of an outer fibrous capsule in the cartilaginous tissue 
grown. Another drawback associated with the rotating wall systems is that growth of tissue is 
usually non-uniform (Chen and Hu, 2006; Freed and Vunjak-Novakovic, 1997). The 
centrifugal force does improve mass transport, but causes the scaffolds to frequently collide 
with the bioreactor wall. This induces cell damage and disrupts cell attachment and matrix 170 
deposition on the scaffolds (Goldstein et al., 2001). Wiesmann et al. (2004) state further 
limitation of spinner flasks by noting that as these bioreactor systems require individual 
manual handling for medium exchange, cell seeding, etc., ultimately limit their usefulness 
when large cell numbers are required. It is understood that sometimes one may need to 
operate at low cell densities (e.g. for contact inhibition, reduced proliferation rates, enhanced 175 
differentiation), but this differs from our aim to produce 3D bone tissue of clinical 
dimensions. We agree with Martin and Vermette’s (2005) opinion that spinner flasks and 
rotating wall vessels are of limited use to grow large tissue mass. 
  
It is evident from the above discussion that characterizing nutrient transport in bioreactors is 180 
critical in the effort to grow bone tissue constructs of clinical value. However, these 
bioreactors are generally very small in size (our HFMB is 3.0cm in length, with each hollow 
fiber module having a 0.4mm extracapillary space between each other) and this makes in situ 
monitoring of concentration distribution very difficult with current monitoring technology. 
Furthermore, the bioreactors operate under stringent conditions (specific cell-culture and 185 
sterile conditions, etc.). Due to these particulars, computational modelling is increasingly 
being used to understand the mass transport behaviour in the bioreactors and to characterize 
their functions at different operating conditions (Das, 2007; Abdullah and Das, 2007; Ma et 
al., 2007; Sengers et al., 2007; Abdullah et al., 2006; Ye et al., 2006). While there are 
different bioreactors, it seems there is no systematic comparison of these bioreactors to 190 
confirm the suitability / effectiveness of these bioreactors for BTE. In particular, there is a 
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lack of computational or experimental study to confirm the assertion that HFMB is more 
suitable for growing bone tissues. To address this issue, we use computational modeling to 
carry out a systematic comparison of three bioreactors which are expected to justify which of 
these bioreactors are better suited for growing bone tissues (at high cell densities). We define 195 
that the suitability of the bioreactors is governed by the need to obtain high cell density in 
bone tissues of clinical size. However, the comparisons of the bioreactors are made by 
characterizing nutrient transport for given cell density. The mathematical frameworks are 
presented for nutrient transport in hollow fiber membrane bioreactor (HFMB), the confined 
perfusion bioreactor (CPB) and the suspended tube bioreactor (STB). These bioreactors are 200 
specifically chosen to represent a sophisticated perfused type, a simple perfused type and 
simple culture dish/flask type bioreactors (non-perfused), respectively, in terms of their 
geometrical configurations. 
 
2. Governing model equations 205 
2.1  Hollow fiber membrane bioreactor (HFMB) 
In this work, we use the Krogh cylinder approximation of HFMB for developing the 
numerical model. This allows us to define the HFMB as composed of many identical fibers 
and the same flow and transport behaviour within each fiber (Abdullah and Das, 2007; 
Brotherton and Chau, 1996; Labecki et al., 1996, 1995; Taylor et al., 1994; Kelsey et al., 210 
1990; Bruining, 1989; Apelblat et al., 1974). A representative diagram of Krogh cylinder can 
be seen in Figure 3. The figure reveals the three main Krogh cylinder sections, namely, the 
lumen, membrane wall and the extracapillary space (ECS). The regions labelled R1, R2 and R3 
represent the radius of the fiber lumen, R1 plus membrane wall thickness and R2 plus the 
thickness of the ECS, respectively. In this work, the HFMB domain is defined as a 2-D Krogh 215 
cylinder representation in an axisymmetrical co-ordinate system, also shown in Figure 3. In 
the figure, segments A1, A2 and A3 represent the lumen radius, the membrane wall thickness 
and half of the total ECS thickness, respectively. 
 
In order to model nutrient transport in the HFMB, steady state equations of conservation of 220 
momentum and mass are solved simultaneously. All governing equations (conservation and 
boundary equations) needed to simulate nutrient transport behaviour in the HFMB are defined 
in the following sections. 
 
2.1.1  HFMB Lumen 225 
We define the fluid motion in the lumen region to be incompressible and steady. The 
conservation of motion is governed by the equations (1) and (2) in stationary (Eulerian) co-
ordinate system. Equation (1) is the Navier-Stokes (NS) equations for conservation of fluid 
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momentum, whilst equation (2) represents conservation of fluid mass (incompressible fluid). 
The boundary conditions (BCs) describe axial symmetry conditions (3a), no slip at the wall 230 
(3b), a fully developed parabolic flow profile at the entrance of the lumen (3c) and normal 
outlet condition (3d), respectively. In these equations, η denotes fluid dynamic viscosity (kg 
m-1 s-1), uv  is the velocity vector (m s-1), uavg is the average fluid velocity, u  and v are the 
velocity components in the axial (z) and radial (r) directions (m s-1), ρ  is density (kg m-3) and 
F
v
 is the force vector (kg m s-2). 235 
 
Conservation of fluid momentum:  Fpu)u(u2
vvvr =∇+∇⋅ρ+∇η−    (1) 
Conservation of fluid mass:  0u =⋅∇ v       (2) 
BCs:  0
r
v
r
u =∂
∂=∂
∂
at 0r =                     (3a) 
u = v = 0 at 1Rr =        (3b) 240 
)R/r1(u2v 21
2
avg −= , u = 0 at 0z =                       (3c) 
p = 0, z=L1        (3d) 
 
The equation for conservation of nutrient mass in the lumen is represented by equation (4), 
which is subjected to BCs as in equations (5a-d). In the fiber lumen, the nutrient transport is 245 
mainly achieved by means of axial convection and diffusion. We define that in this region 
(lumen), the nutrient transport velocity is the same as fluid velocity field ( uv ), determined 
from equations 1, 2, 3a and 3b. 
 
Conservation of nutrient mass:  ( ) cucD1 ∇⋅−=∇−⋅∇ v     (4) 250 
BCs: 0cc =  at 0z =        (5a) 
 ( ) ( )ucnuccDn 1 vvvv ⋅=+∇−⋅  at 1Lz =      (5b) 
0
r
c =∂
∂
 at 0r =        (5c) 
r
cD
r
cD 21 ∂
∂=∂
∂
at 1Rr =       (5d) 
 255 
As evident, four BCs are defined. The first BC (5a) is a Dirichlet type BC representing the 
inlet concentration at the entrance to the lumen. Equation (5b) and (5c) are Neumann type 
BCs corresponding to convective flow (outlet) and axial symmetry at the centre of the lumen. 
The fourth BC (5d) is also a Neumann type BC and accounts for the conservation of flux at 
the lumen wall. In the above and subsequent equations, L1 is the effective HF length, c is 260 
concentration (mol m-3), nv  is unit vector perpendicular to the boundary and the parameter D 
with subscripts 1, 2 and 3 refers to the diffusivity values of a nutrient in the lumen (A1), fiber 
membrane wall (A2) and cellular matrix (A3), respectively. 
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2.1.2  HFMB Fiber Membrane Wall  265 
In the fiber membrane wall, we define equation (6) to represent conservation for nutrient mass 
with respect to equations (7a-c) as boundary equations. Equation (6) describes the nutrient 
conservation equation with zero fluid velocity as there is no fluid flow in the membrane. 
Here, we define the membrane region having no convection and nutrient transfer is via 
diffusion only. BC (7a) is identical to the BC (5d) in the lumen and along with (7b) accounts 270 
for the conservation of flux at the membrane boundaries with the lumen and ECS 
respectively. BC (7c) meanwhile accounts for insulation where nothing passes in or out of the 
boundary. 
 
Conservation of nutrient mass:  ( ) 0cD2 =∇−⋅∇     (6) 275 
BCs: 
r
cD
r
cD 21 ∂
∂=∂
∂
 at 1Rr =                       (7a) 
r
cD
r
cD 32 ∂
∂=∂
∂
 at 2Rr =       (7b) 
( ) 0cDn 2 =∇−⋅v  at z = 0, L1      (7c) 
 
2.1.3  HFMB Extracapillary Space (ECS)  280 
In the extracapillary space (ECS), we define equations (8a-b) to represent conservation for 
nutrient mass, with respect to equations (9a-c) as boundary equations. 
 
Conservation of nutrient mass:  ( ) RˆcD3 =∇−⋅∇    (8a) 
dVRˆ ×−=     (8b) 285 
 BCs: 
r
cD
r
cD 32 ∂
∂=∂
∂
 at 2Rr =       (9a) 
( ) 0cDn 3 =∇−⋅v at z = 0, L1      (9b) 
0
r
c =∂
∂
 at 3Rr =        (9c) 
 
Equation (8a) shows that the rate of diffusion is related to the product reaction rate, Rˆ . In 290 
equation (8b), we define that reaction rate, which is also the cell nutrient consumption rate to 
be of zero order kinetics. By defining the reaction rate this way, we aim to show the worst 
case scenarios for concentration distributions (i.e., nutrient deficiencies) under different 
conditions. This issue was discussed in detail in our previous papers (Abdullah and Das, 
2007; Abdullah et al., 2006; Ye et al., 2006). In brief, zero order kinetics was chosen because 295 
our inlet concentration used based on the manufacturer’s formulation (Ye et al., 2006) is 
about 1000 times higher than reported values of the Michaelis-Menten constant, Km (Ma et 
al., 2007). Although the most common rate expression is of Michaelis-Menten type, that rate 
of expression reduces to zero order kinetics at high nutrient concentrations, i.e. where Km is 
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much smaller than concentration, c (Fujimiya et al., 1999; van Wensem et al., 1997; 300 
Brotherton and Chau, 1996). In the above equations, variables V and d are defined as cell 
metabolic rate for glucose (mol cell-1 s-1) and cell seeding density (cells m-3), respectively. 
BC(9a) is similar to BC (5d), while BCs (9b-c) reflect containment at both ends of the ECS 
and the symmetry of the concentration gradients between adjacent hollow fibers respectively. 
 305 
2.2 Confined perfusion bioreactor (CPB) 
For the purpose of our numerical simulations, we define that the CPB is divided into three 
sections which are the lumen, the membrane wall and the scaffold construct. This is 
represented in Figure 2. Section B1, which is the lumen, is similar to the fiber lumen in the 
HFMB. It is through here that the nutrients and growth factors are supplied to, and wastes 310 
removed from the bioreactor. Region B2 or the membrane wall is porous and semi-permeable 
to certain solutes such as nutrients and oxygen. The third section, B3, represents the scaffold 
matrix construct which will support the bone tissue cells and allow them to grow and 
proliferate. Symbols R4, R5 and R6 represent the scaffold boundary, membrane boundary and 
outer boundary of the CPB, respectively. 315 
 
The governing equations associated with the CPB are comparable to those for the HFMB. It 
again involves the simultaneous solution of the equations for steady state conservation of 
momentum in the lumen region combined with the conservation of mass in all three 
previously defined regions. All governing equations used to simulate nutrient transport 320 
behaviour in the CPB are defined as follows. 
 
2.2.1  CPB Lumen 
As in the HFMB, the fluid motion in the lumen region of the CPB is incompressible and 
steady. Therefore, the same equations (1) and (2) are used to govern the conservation of 325 
momentum and mass of the fluid respectively, in the CPB. These equations are subject to the 
BCs as depicted by equations (10a-d). BCs (10a) and (10b) describe axial symmetry and no 
slip boundary conditions; BC (10c) describes a fully developed parabolic flow profile at the 
inlet, while BC (10d) describes the outlet. Symbol x in (10b) is the radial distance of the CPB 
lumen. 330 
 
Conservation of fluid motion and fluid mass: 
 Equations (1) and (2) 
 BCs: 0
r
v
r
u =∂
∂=∂
∂
at 0r =                  (10a) 
u = v = 0 at r = x, R5, R6                            (10b) 335 
)x/r1(u2v 22avg −= , u = 0 at 0z =                (10c) 
 10
p = 0,  z=L1                  (10d) 
 
The conservation of mass (nutrient) equations for each region and their respective BCs are 
almost identical to those in the HFMB. In the CPB lumen, conservation of nutrient mass is 340 
represented by equation (11), whilst equations (12a-e) represent the BCs. Symbols 4D , 5D  
and 6D  are the diffusivity values of nutrient (m
2 s-1) in the lumen, membrane, and scaffold 
construct in CPB, respectively. L2 meanwhile is the CPB effective length of CPB. 
 
Conservation of nutrient mass:  ( ) cucD4 ∇⋅−=∇−⋅∇ v   (11) 345 
 BCs: 0cc =  at 0z =                 (12a) 
 ( ) ( )ucnuccDn 4 vvvv ⋅=+∇−⋅  at 2Lz =                (12b) 
0
r
c =∂
∂
 at 0r =                                             (12c) 
( ) 0uccDn 4 =+∇−⋅ vv  at r = x, R6               (12d) 
r
cD
r
cD 54 ∂
∂=∂
∂
at 5Rr =                 (12e) 350 
 
2.2.2  CPB Fiber Membrane 
In the fiber membrane, conservation of mass (nutrient) is represented by equation (13), with 
equations (14a-c) being the BCs.  
 355 
Conservation of nutrient mass:  ( ) 0cD5 =∇−⋅∇    (13) 
BCs: 
r
cD
r
cD 54 ∂
∂=∂
∂
at 5Rr =                 (14a) 
r
cD
r
cD 65 ∂
∂=∂
∂
at 4Rr =                 (14b) 
0
r
c =∂
∂
at 0r =                       (14c) 
 360 
2.2.3  CPB Scaffold Construct 
In the scaffold construct, equations (15a-b) are defined to correspond for conservation of 
mass (nutrient), subjected to equations (16a-b) as boundary conditions respectively. 
 
Conservation of nutrient mass:  ( ) RˆcD6 =∇−⋅∇              (15a) 365 
dVRˆ ×−=               (15b) 
 BCs: 
r
cD
r
cD 65 ∂
∂=∂
∂
at 4Rr =                 (16a) 
0
r
c =∂
∂
at 0r =                  (16b) 
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2.3 Suspended tube bioreactor (STB) 370 
We define that the STB has two sections, as in Figure 1. The first section, C1, represents 
nutrient rich solution which is in the bioreactor vessel while the second section, C2, 
corresponds to suspended scaffold construct with bone tissue cells within. R7 and R8 are 
defined as radius of the flask and radius of the scaffold construct, respectively. 
 375 
No flow is considered in the STB (as we introduce it as a non perfused system). We define 
that the medium is well mixed. Thus, the only equations for conservation of mass (nutrient) 
are used in the defined domains. The cylindrical geometry of the STB is set in a 2-D 
axisymmetrical coordinate system for the numerical simulations. The governing equations for 
the STB are given as follows.  380 
 
2.3.1  STB Vessel 
Equation 17 represents conservation of mass (nutrient) in the STB vessel, subjected to 
boundary conditions in equations (18a-c).  
 385 
Conservation of nutrient mass:  ( ) 0cD7 =∇−⋅∇    (17) 
 BCs: 0
r
c =∂
∂
at 0r = ,                            (18a) 
  ( ) 0cDn 7 =∇−⋅v at r = R7, z = 0, L3                (18b) 
r
cD
r
cD 87 ∂
∂=∂
∂
at r = R8, z = z1, z1 + z2                                      (18c) 
 390 
2.3.2  STB Scaffold Construct 
In the scaffold construct, conservation of mass (nutrient) is represented by equations (19a-b). 
Boundary conditions for this domain are represented by equations (20a-b). Symbols 7D  and 
8D in the above mentioned equations are the diffusivity values of given nutrient species (m
2 s-
1) in the vessel and scaffold of the STB respectively. L3 meanwhile is the effective length of 395 
the STB, defined by the height level of nutrients in the STB vessel. 
 
 Conservation of nutrient mass:  ( ) RˆcD8 =∇−⋅∇              (19a) 
dVRˆ ×−=               (19b) 
BCs: 
r
cD
r
cD 87 ∂
∂=∂
∂
at r = R8, z = z1, z1 + z2                           (20a) 400 
0
r
c =∂
∂
 at 0r =                                         (20b) 
 
2.4 Model parameters 
 12
In this work, we use constants and operational parameters which are the same as used in our 
previous studies (Abdullah and Das, 2007; Das, 2007; Abdullah et al., 2006; Ye et al., 2006). 405 
These are detailed in Table 1. The significant parameters of the HFMB (e.g. fiber diameter, 
membrane thickness etc) are referred from the same above mentioned source. As these values 
(Table 1) are taken directly from in-house experiments, they also reflect laboratory 
conditions.  
 410 
The geometry of the CPB (Table 1) is chosen to give a scaffold size that would provide cell 
tissues of comparable size to the HFMB and so provides a good comparison between the two 
reactors. In Table 1, the magnitudes of the parameters in the radial direction are ten times 
greater in the CPB than the HFMB. The geometry of the STB is similar to the suspended tube 
model proposed by Sengers et al. (2005) and reflects a realistic non-perfused bioreactor. 415 
 
2.5 Solving governing equations, boundary conditions and model parameters 
The numerical solutions to the governing equations have been obtained using FEMLAB. 
When solving the governing partial differential equations (PDEs) the software applies finite 
element method (FEM) to discretise and solve the PDEs (FEMLAB User’s Guide, 2004). 420 
FEMLAB runs the finite element analysis together with adaptive meshing and error control 
using a variety of iterative numerical solvers. FEMLAB generates a mesh that is tetrahedral in 
shape and isotropic in size. A vast number of elements can then be created with or without 
any scaling requirements. In our simulations for HFMB, a scaling factor of 10 has been used 
in the radial direction due to the significant difference in the magnitude of r (radial distance) 425 
and z (axial distance). The geometry is automatically scaled back after meshing. This 
generates an anisotropic mesh and the HFMB geometry has 2,202 elements with 8,726 
degrees of freedom (DOF) instead of 22,125 elements and 87,133 DOF. For the CPB we use a 
mesh consisting of 4,278 elements and have 31,860 DOF while for the STB’s geometry, 311 
elements and 681 DOF are used.  430 
 
We performed simulations with different mesh sizes, which are within the range of 
FEMLAB’s predefined mesh size schemes, e.g., ‘extremely course’, ‘extra course’, ‘courser’, 
‘course’, ‘normal’, ‘fine’, ‘finer’, ‘extra fine’ and ‘extremely fine’. Statistics of number of 
element and DOF for ‘extremely course’, ‘normal’ and ‘extremely fine’ schemes for our 435 
HFMB Krogh cylinder framework are 1248-6401, 2202-8276 and 4722-16596, respectively. 
Varying the mesh schemes (using the three previously mentioned predefined mesh scheme), 
showed results with very small difference in concentration value when they are compared 
(typically <1% difference). We realize that if we continued to use coarser grids, the mesh 
sizes may affect the simulation results slightly. We did further simulations on our framework 440 
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(Krogh cylinder) with finer mesh scales (up to 140982 elements) and obtained small 
differences in the concentration profiles. We believe that this illustrates that the mesh sizes 
that we used for our simulations are fine enough to give converged numerical results. In order 
to get a good comparison between the bioreactor domains, we used the same predefined 
FEMLAB mesh sizes (predefined mesh scale is being set at normal) for each bioreactor.Using 445 
different mesh grids and scaling factors to descritize the defined domains may give significant 
effect on simulation results. In our case, as discussed by Ye et al. (2006), our current 
simulations give small concentration difference when meshes of 2,202 elements and 140,928 
elements were compared. In order to get a good comparison, we used the same predefined 
FEMLAB mesh sizes (predefined mesh scale is being set at normal) for each bioreactor (each 450 
with DOFs and elements as mentioned in the previous paragraph). Small differences may be 
observed with addition of scaling coefficients. This is because FEMLAB automatically scales 
back the geometry after meshing (Ye et al., 2006).  
 
As previously mentioned, validity of the results is difficult to obtain due to the very small 455 
laboratory scale of the bioreactors. Experiments carried out by Ye et al. (2004) found that 
only collective concentration change at the inlet and outlet of the bioreactor could be 
monitored at different time. It was not possible to monitor localised concentration data within 
the bioreactor. Further, the experimentally measured concentrations do not reflect what may 
happen at steady state conditions. This created a problem in that the results obtained from the 460 
FEM package cannot be directly compared to experimental results for model validation. 
However, due to the inherent nature of FEM, mass is conserved in the domain. Furthermore, 
the developed scheme has been validated against benchmark solutions as discussed by and 
Abdullah and Das (2007), Abdullah et al. (2006) and Ye et al. (2006). For brevity, they are 
not discussed in this paper.  465 
 
3. Results and discussions 
In this section, we present our simulation results for nutrient transport behaviour. It is divided 
into three main parts which cover the hydrodynamics and nutrient transport behaviour in all 
three bioreactors (HFMB, CPB and STB). In our previous papers on HFMB (Abdullah and 470 
Das, 2007; Abdullah et al., 2006; Ye et al., 2006), we have shown that at high cell densities, 
glucose rather than oxygen is the limiting nutrient. Consequently, only glucose concentration 
profiles are considered for the purpose of this paper.  
 
In an effort to ensure that ample amounts of nutrients are available for cells to metabolize, we 475 
argue that nutrient concentration in the bioreactors are more critical in areas / domains where 
cells are grown (e.g., ECS) as compared to other areas (e.g., lumen). Therefore, our 
 14
concentration profile results will mainly be shown in areas where there is cell growth, i.e. the 
ECS in the HFMB and, the scaffold matrix in the CPB and STB. For our work, all simulations 
define a zero order consumption rate in continuation of our previous work. The effects of the 480 
rate of reaction have been considered in a previous work (Abdullah et al., 2006). 
 
3.1 Fluid flow and mass transfer characteristics 
In this section, we present the fluid flow and mass transfer characteristics in the HFMB, CPB 
and STB, respectively. These are presented in an attempt to characterize and compare the 485 
hydrodynamics in those bioreactors. We start doing so by defining three important 
dimensionless parameters for each bioreactor, namely, the Reynolds (Re), Peclet (Pe) and 
Damkohler (Da) numbers. They are defined as below: 
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 500 
Re and Pe numbers are only calculated in the lumen of HF and CPB, where velocity is 
defined. As for Da, it is only determined in HF ECS, CPB and STB scaffold construct, 
respectively (where reactions take place). For equations (21a-j), ρ is defined as fluid density 
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(kg m-3), uavg is average fluid velocity (m s-1), Lc is the characteristic length or lumen diameter 
(m) of CPB and the fiber module in HFMB and η is the dynamic fluid viscosity (kg m-1 s-1). D 505 
with subscripts are similar to what was previously defined, n is defined as reaction order 
while A is defined as interfacial surface area with subscripts 3, 6 and 8 represents domains of 
the HF Krogh cylinder ECS and scaffold constructs of CPB and STB respectively.  
 
We have calculated Re and through equation (21a-c). For calculation of Re, the density 510 
variation in the lumen is discarded because of a few reasons. One, the glucose concentration 
in the lumen is very dilute (5.55 mol m-3) and the weight of nutrients is very small compared 
to water to be giving effective variation on overall density. Secondly, the temperature and 
pressure is kept constant and any variations of these parameters inside the bioreactors are too 
small to influence the overall fluid density. Due to this, it is safe enough to estimate the fluid 515 
properties using water properties at 310K (37oC). From above equations (21b-c), the 
Reynolds number in the HF module in HFMB is 2.138 while Re in CPB is 21.38. Both values 
imply laminar flow (Re << 2100). Re values also shows that inertial forces in the HFMB and 
CPB are 2.138 and 21.38 times higher than the viscous forces. Viscous forces in the HF 
module and CPB are defined to be the same, but CPB has inertia forces 10 times larger than a 520 
single HF module. This is because CPB has an Lc value of 10 times larger, when all other 
operational parameters (ρ, u and μ) are the same. 
 
As for Pe values obtained from equation (21d-f), it is revealed that Pe in HFMB is at 2759.26 
while CPB is 10 times higher at 27592.6. This implies that rate of flow advection in an HF 525 
module and CBP lumens are 2759 and 27592 times higher than the rate of diffusion 
respectively. It is obvious that CPB has a Pe 10 times higher than HFMB, due to similar 
reasons explained in the previous paragraph. The bioreactor is operating in a convective 
dominant regime when Pe >> 1. Hence, in the lumen, solute transport is achieved by 
convection. 530 
 
The Da values for zero order kinetics and with similar operating conditions, are 28.91 for an 
HF module in HFMB, 32.11 for CPB and 321.18 for STB, from equation 21(g-j). This 
implies that under the specified conditions for all three bioreactors, the chemical reaction rate 
(nutrient uptake by the cells) is high compared to mass transport rate. In other words, these 535 
bioreactors are diffusion limited when Da >> 1 (Gervais and Jensen, 2006; Mousavi et al., 
1999).  
 
3.1.1 Hollow fiber membrane bioreactor (HFMB) 
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Under the control parameters (Table 1), the simulated fluid flow and mass transfer 540 
characteristics of the HFMB can be seen in Figures 4(a-d). Figure 4(a) shows the magnitude 
of fluid velocity field in the HFMB lumen. As expected, the flow profile in the lumen is 
parabolic. Figure 4(b) shows that the diffusive flux in the membrane and ECS regions is in the 
radial direction. This is expected as the concentration gradient is in the radial direction and 
the nutrients diffuse along the same direction of concentration gradient according to the 545 
governing equations. Figures 4(c,d) show that the inlet of the HFMB is at a higher pressure 
while the outlet is at zero (gauge) pressure, similar to the profiles produced by Brotherton and 
Chau (1996). It is this pressure gradient that drives the fluid through the lumen region.  
 
3.1.2 Confined perfusion bioreactor (CPB) 550 
The simulated fluid flow and mass transfer characteristics in the confined perfusion bioreactor 
for control parameters are shown in Figures 5(a-d). It can be seen in Figure 5(a) that the flow 
profiles in the CPB are parabolic although the fluid velocity is low around the middle of the 
reactor. Figures 5(b,c) show that the diffusive flux in the membrane and ECS regions is in the 
radial direction towards the centre of the bioreactor. This conforms to what is expected from 555 
the governing equations. Figure 5(d) meanwhile shows the pressure gradient that drives the 
flow through the lumen region. 
 
3.1.3 Suspended tube bioreactor (STB) 
The mass transfer characteristics for the simulation of the confined perfusion bioreactor 560 
operating for control parameters can be seen in Figure 6. There is no fluid flow profile 
associated with the STB. Figure 6 shows that the mass transfer processes in the STB are 
dominated by diffusive mechanisms. The magnitude of the flux is seen the greatest close to 
the scaffold. 
 565 
3.2 Nutrient concentration profiles 
The results discussed in this section are for the parameter values in Table 1, which reflect in-
house laboratory experiments (Abdullah et al., 2006; Ye et al., 2006). 
 
3.2.1 Hollow fiber membrane bioreactor (HFMB) 570 
The axial and radial concentration profiles for glucose in the HFMB are shown in Figure 7. 
The figure shows that glucose concentration is available to maintain cell growth throughout 
the ECS domain (under controlled conditions). It can be seen that the axial variation of 
glucose concentration is very small while its radial profile shows a greater drop in 
concentration towards the outer radius of the hollow fiber. Radial concentration variations are 575 
larger because increasing radial distance is effectively moving further away form the nutrient 
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source. Furthermore, the radial nutrient transport depends on diffusion mechanism through 
the membrane wall and ECS. The lateral changes in concentration are consistent with the 
HFMB behaviour predicted earlier and were reported by various researchers, among others, 
Abdullah and Das (2007), Brotherton and Chau (1996) and Heath and Belfort (1987). 580 
 
3.2.2 Confined perfusion bioreactor (CPB) 
The axial and radial glucose concentration profiles in the CPB are shown in Figure 8. The 
figure shows that glucose concentration in the CBP decreases towards the centre of the 
scaffold. Similarly to the HF Krogh cylinder, the CPB scaffold centre has the lowest nutrient 585 
concentration because it is furthest from the nutrient source. Again, nutrient transport is fully 
dependent on diffusion mechanisms alone to allow glucose to be delivered to the centre. The axial 
profile is seen symmetric because the defined diffusion coefficient and nutrient uptake rate 
(reaction rate) are kept constant throughout the scaffold. The scaffold centre has the lowest 
nutrient concentration because it is furthest from the nutrient source. Furthermore, it is fully 590 
dependent on diffusion mechanisms alone to allow glucose to be transported to the area. The 
scaffold centre of the CBP is left with only ≈10% of the inlet glucose concentration (c0). This 
glucose concentration is unlikely to sustain cell growth. The profiles obtained here are similar 
to what were reported by Sengers et al. (2005). 
 595 
3.2.3 Suspended tube bioreactor (STB) 
The axial and radial glucose concentration profiles in the STB are shown in Figure 9. The 
negative concentration values imply the amount of nutrients that are deprived from the cells 
in the scaffold domain. The figure suggests that glucose concentration is severely inadequate 
to maintain cell growth in the scaffold domain. Such glucose deficiency will ultimately lead 600 
to cell death. This implies that the STB may not be a feasible bioreactor for growing high cell 
density bone tissues. The profiles showed here are somewhat of similar trend to what were 
discussed by Sengers et al. (2005). In our work, we have the same cell density in the CPB and 
HFMB to make a direct comparison possible. 
 605 
3.3 Effects of process design parameters 
The glucose concentration profiles presented in this section are from further simulations that 
are carried out by varying a parameter of interest, whilst keeping the other parameters the 
same. By comparing the profiles obtained from the variations of chosen parameters against 
the control cases, the manifestation of various parameters on nutrient transport behaviour in 610 
each bioreactor are determined. There are a number of design parameters affecting the mass 
transfer characteristics of the bioreactors. In this section, the effects of inlet glucose 
concentration (c0), inlet velocity (u), cell density (d) and hindering factor (β) on nutrient 
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concentration profiles are observed. The reasons why these parameters are chosen are 
explained in the sections to follow.  In this section, concentration profiles in the HFMB are 615 
represented by only radial profiles, whilst the CBP and STB will be represented by axial 
profiles only. We have decided to choose these profiles because more significant transport 
limitations are shown radially in the HFMB (as opposed to axially in the said bioreactor) and 
axially in both CPB and STB (as opposed to radially in both) under control conditions.  
 620 
3.3.1 Effect of inlet glucose concentration (c0) 
The inlet concentration of nutrients is an important parameter in the design of a bioreactor and 
it is important to understand how change of inlet glucose concentration (c0) influences the 
mass transfer behaviour in the bioreactors. The previous simulations in this paper have been 
carried out for inlet concentration of 5.55 mol m-3, which reflects the laboratory scale 625 
experiments (Ye et al., 2006). In this section, we have simulated bioreactor operations with 
different nutrient inlet concentrations. This is done with the aim to observe whether glucose 
transfer limitations observed under control conditions can be sufficiently reduced by varying 
inlet concentrations. This corresponds to a logical and direct answer/solution for nutrient 
deficiency, which is to increase the supply of nutrients. With slight note of caution, it must be 630 
pointed out that it is important to understand that cell deaths are not only related to lack of 
nutrients. It is also possible to kill cells by supplying them with too high concentrations of 
nutrient. Furthermore, supplying too much nutrient may not be the best solution in terms of 
cost and maintenance. The ranges of glucose concentrations have been continued from those 
chosen by Abdullah and Das (2007), Das (2007), Abdullah et al. (2006) and Ye et al. (2006). 635 
The effects of inlet glucose concentrations are shown in Figures 10 and 11 for HFMB, and 
CPB respectively. 
 
In general, these figures show that increasing c0 values leads to higher nutrient availability in 
the extracellular regions. Figures 10 and 11 show that increasing the glucose inlet 640 
concentration in the HFMB and CPB produce elevated concentration profiles (higher 
concentration values). For example, the lowest point of c/c0 in the CPB increases from 0.1 
(for glucose inlet concentrations of 5.55 mol m-3) to c/c0 ≈ 0.41 (for inlet concentrations of 
8.50 mol m-3). This improvement enhances the possibility of the CPB to sustain growth of 
cells at high densities, which is crucial in producing clinically viable bone tissue constructs. 645 
However, the large variation in glucose concentration (high glucose concentration gradient) 
observed in the CPB as in Figure 11 may lead to an uneven distribution and density of cells. 
In the STB, increasing inlet glucose concentration even up to 8.50 mol m-3, fails to 
significantly improve transport limitations in the scaffold construct. Without ample nutrient 
supply, it seems that the STB is unsuited for growth of cells at high density. The STB 650 
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concentration profiles are similar to Figure 9 and are below zero for all different inlet 
concentrations. Thus, the STB profiles are not shown.   
 
From these simulations, we show that glucose concentration profiles are affected by inlet 
concentrations. It is also shown that nutrient transport limitation can be significantly reduced, 655 
although not completely removed by increasing nutrient inlet concentrations (c0). 
Nonetheless, increasing the inlet glucose concentration does not overly improve the 
performance of HFMB, which implies that an inlet concentration of 5.55 mol m-3 is ample for 
operations at a high cell density (e.g. 2×1012 cells m-3). For CPB, the inlet concentration may 
need to be increased to levels high enough to sustain cell growth at these cell densities 660 
(2×1012 cells m-3). For STB however, increasing inlet glucose concentrations alone is not 
enough to ensure feasibility in growing cells at high density. With slight note of caution, one 
should note that in good condition, the cell number in the ECS or scaffolding matrix should 
increase in time. It may be wise to increase the inlet concentration once cells increase in 
number (cell density increases) in order to maintain similar concentration profiles throughout 665 
the ECS or scaffolding matrix. The effects of cell density on concentration profiles 
throughout each bioreactor are shown in section 3.3.3 in this paper. 
 
3.3.2 Effect of fluid inlet velocity (uavg) 
These simulations involve observing effects of fluid inlet velocity (uavg) on nutrient 670 
concentration. They only apply to the HFMB and CPB due to the fact that no fluid flow 
occurs in the STB. The parabolic flow profile is the same for both bioreactors with only the 
magnitude of uavg changed. The control simulations are carried out at uavg = 7.45×10-3 m s-1. 
Here, we aim to investigate the effects of faster and slower fluid flow on nutrient transport. 
We choose velocities which are ten times greater and smaller than the control conditions. The 675 
results of these simulations are shown in Figures 12 and 13 for HFMB and CPB respectively. 
 
It is interesting to note how differently the inlet velocity changes the glucose concentration 
profiles of the two bioreactors. Figure 12 shows that increasing velocity tenfold has negligible 
effect on glucose concentration profiles in the HFMB. However, decreasing velocity tenfold 680 
(reduced velocity of 7.45×10-4 ms-1) display a significant effect. We may conclude here that 
the control velocity is the optimum velocity to be operated at cell density of 2×1012 cells m-3. 
Glucose concentration profiles in the HFMB are found to be lower, especially at the furthest 
end of the HFMB when operated at the reduced velocity. Unlike the HFMB, inlet velocity 
shows little effect on glucose concentration profiles in the CPB (Figure 13). The glucose 685 
concentration profiles in the CPB show minute changes at both elevated and reduced velocity 
compared to profiles for control fluid inlet velocity. This means that the optimum velocity for 
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CPB is achieved at a reduced average velocity of 7.45×10-4 ms-1. Operating at further reduced 
velocities may result in poor nutrient transport, while further increasing the velocity will not 
improve nutrient transport significantly. 690 
 
It should be noted that the HFMB’s performance is most affected by reducing the inlet flow 
velocity lower than control conditions. However, the concentration profile in the HFMB at 
reduced inlet velocities is relatively high and still adequate enough to maintain cell growth. 
Further simulations under even slower velocities could be carried out to see at what velocity 695 
mass transfer becomes limited to the extent of being unable to sustain the cell culture. 
Increasing inlet flow velocity meanwhile will result in an improved (higher) concentration 
profile throughout the HFMB ECS. However, this is only true up to a certain limiting value of 
velocity. Negligible gains in concentration are achieved if further velocity increment is made 
beyond the said limit (beyond control velocity). As for the CPB, inlet velocity has very small 700 
effect on its nutrient concentration profiles. 
 
3.3.3 Effect of cell density (d) 
The determination of the effects of cell density on mass transfer in the bioreactors is 
important. This is because it helps to identify what bone cell densities may be obtained in the 705 
bioreactors and/or the optimal operating conditions for desired cell densities. In our case, 
operations at high cell densities are desirable as high cell densities give higher chance to 
produce tissues of clinically viable size. The results of the simulations for glucose 
concentration profiles are shown in Figures 14 and 15 for HFMB and CPB respectively. 
 710 
In general, higher cell densities result in greater nutrient consumption. For the HFMB, it can 
be observed from Figure 14 that lower glucose concentration profiles are exhibited at higher 
cell densities (up to 3×1012 cells m-3). However, the concentration profile difference is slight, 
and even at an increased cell density of 3×1012 cells m-3, more than 90% of the initial glucose 
concentration (c0) is still available. This is expected to sustain further cell growth. The results 715 
obtained here correspond with earlier claims by Ye et al. (2006, 2004), Heath and Belfort 
(1987), that HFMB may maintain high nutrient concentrations even at high cell densities. 
 
Meanwhile, Figure 15, which depicts axial glucose concentration profiles in the CPB, shows 
that the bioreactor is not able to cope with cell densities higher than 2×1012 cells m-3. As seen 720 
in the figure, the glucose concentration profile at cell density of 3×1012 cells m-3 exhibits 
critical insufficiency (i.e., below zero concentration values). However, the CPB is able to 
maintain high concentrations of glucose at lower cell densities.  
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Axial glucose profiles at three different cell densities for the STB show severe insufficiency. 725 
Even small concentrations of glucose cannot be maintained throughout the scaffold construct 
in the STB. Glucose is seriously insufficient, even at the lowest simulated cell density (7×1011 
cells m-3). It seems that the STB may not be used for cell densities up to 7×1011 cells m-3, 
although it may be used for BTE applications at lower cell densities. As all the concentration 
values within the STB are below zero (comparable to Figure 9), the profiles are not shown.   730 
 
Increasing the cell density will increase mass transfer limitations in all three bioreactors. 
When designing bioreactors, it is important to determine the maximum cell densities 
achievable and adapt the operating conditions to achieve the desired density. From our 
simulations, we have shown that the STB is unsuited even at relatively low cell densities of 735 
7×1011 cells m-3. We have also illustrated that the CPB may not be feasible at cell densities 
above 2×1012 cells m-3 while the HFMB is very much capable of sustaining cell densities even 
at 3×1012 cells m-3. 
 
3.3.4 Effect of scaffold hindering factor (β) 740 
We define hindering factors as the ratio of diffusivity of a substrate in water to its effective 
diffusivity in another medium. The membrane hindering factor (α) and scaffold hindering 
factor (β) are defined in Table 1. Hindering factors of membrane may vary due to difference 
in material properties (e.g. different pore sizes, tortuosity etc.). In a previous work, α was 
assumed to be 10 by Waterland et al. (1974) in their theoretical model for enzymatic catalysis 745 
using asymmetric hollow fiber membranes. Davis and Watson (1985) also reported an α value 
of 10 in their work. Others reported α values for glucose include 15 in dialysis membranes at 
12 kD MWCO (molecular weight cut-off) (Myung et al., 2006) and 34 for regenerated 
cellulose at 3.5 kD MWCO (Marucci et al., 2007). Trujillo (1987) meanwhile, using nylon 
membrane, reported an α value of around 50 for uric acid. It is very unlikely that membrane 750 
with such a large hindering factor will be used for tissue engineering purposes. Our study 
relates to cellulose acetate HF modules with 10kDa MWCO. In the following simulations, we 
define a constant value of the membrane hindering factor (α) of 10. However, values for the 
scaffold hindering factors are not necessarily known with certainty and are often based on 
experimental results. Thus, variations for β will be simulated in this section. In actual practise, 755 
variations of β may represent different scaffolding materials, or conditions when diffusion 
coefficient decreases after time (e.g. once bone matrix grows, the effective diffusion 
coefficient values in the scaffold construct decreases and thus makes β values higher). Due to 
its high porosity (up to 90% in some cases), β value is estimated initially to be half of α, 
which is 5 (Willaert et al., 1999). Concentration profiles in HFMB and CPB with different β 760 
values are shown in Figures 16 and 17, respectively. 
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The simulations carried out under varying hindering factors (β) exhibit similar trends to 
simulations carried out under varying cell densities. Higher β values resulted in lower 
concentration levels. Nonetheless, the HFMB is able to maintain significantly high glucose 765 
concentration profiles (Figure 16) even at increased hindering factor values.  
 
Figure 17 shows the concentration profile of glucose in the CPB respectively. From that 
figure, it is evident that the CPB is unable to sustain ample concentrations of glucose at 
increased β values. As for the STB, simulation results suggest severe glucose insufficiency 770 
with concentration values being below zero (results not shown). The severity is evident even 
at lower membrane hindrance factor values, thus it further reflects that the STB may not be 
suitable to operate under our proposed operating conditions. 
 
4. Conclusion 775 
A systematic comparison of three bioreactors, namely, the hollow fiber membrane bioreactor 
(HFMB), the confined perfusion bioreactor (CPB) and the suspended tube bioreactor (STB), 
has been carried out in this work using numerical experiments. It is clear that the HFMB is 
the most effective bioreactor for growing bulky (3-D) bone tissue. Under no operating 
conditions does the STB look a feasible bioreactor and it is generally hampered by mass 780 
transfer limitations. Coupled with the lack of mechanism for removing waste products, it is 
possible that the STB cannot be utilised to grow bone tissues under the operating conditions 
(especially at high cell densities) used in this work. While the CPB does not perform as well 
as the HFMB, it does have the potential to develop into a design capable of growing bulky 
bone tissues. Further tests should be carried out with a smaller scaffold domain to determine 785 
if the glucose transport limitations can be overcome. With the nutrient supply entering the 
bioreactor in the radial direction, it would be possible in theory to have a very long bioreactor 
capable of growing tissues on a larger scale than possible in the HFMB. However, the HFMB 
holds a significant advantage over all kinds of bioreactors, in that when the bones are 
implanted into the human body, the existing hollow fibers could form a capillary network 790 
allowing the transplanted bones to survive in vivo. 
 
In this paper, we have showed that the HFMB is potentially a good choice in order to grow 
3D bone tissue constructs. Our simulation results showed that the HFMB is able to maintain 
higher nutrient concentrations compared to the STB and CBP during operation. Furthermore, 795 
the HFMB performs well even at high cell densities, unlike the STB (which is unsuited at all 
at high densities) and the CPB (which gave mixed results at high cell densities). By varying 
the HFMB operational parameters, better mass (nutrient) transport can be achieved and 
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substantially a high nutrient concentration profile can be maintained. This reemphasises the 
fact that the HFMB has indeed the qualities to produce 3D bone tissue constructs of clinical 800 
value. 
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Nomenclature 
Symbol Description Units 
C concentration mol m-3 
c0 inlet glucose concentration mol m-3 
D cell density cells m-3 
D diffusion coefficient m2 s-1 
D1 diffusivity in HFMB lumen m2 s-1 
D2 diffusivity in HFMB membrane wall m2 s-1 
D3 diffusivity in HFMB extracapillary space (ECS) m2 s-1 
D4 diffusivity in CPB lumen m2 s-1 
D5 
D6 
D7 
D8 
diffusivity in CPB membrane wall 
diffusivity in CPB scaffold construct 
diffusivity in STB vessel 
diffusivity in STB scaffold construct 
m2 s-1 
m2 s-1 
m2 s-1 
m2 s-1 
Lc 
L1 
L2 
L3 
characteristic length 
effective fiber length 
effective CPB length 
effective STB length 
m 
m 
m 
m 
n reaction order - 
nv  unit vector perpendicular to the boundary - 
r radial distance m 
Rˆ  reaction term (zero order, in this paper) dimensionless  
R1 fiber inner radius m 
R2 fiber outer radius m 
R3 
R4 
R5 
R6 
R7 
R8 
Krogh cylinder radius 
CPB scaffold construct radius 
CPB membrane radius 
CPB outer boundary radius 
radius of STB vessel 
radius of STB scaffold construct 
m 
m 
m 
m 
m 
m 
Re Reynolds number dimensionless 
u velocity component in axial (x) direction  m s-1 
uv  fluid velocity field m s-1 
uavg fluid average velocity m s-1 
v velocity component in radial (r) direction m s-1 
V cell metabolic rate for glucose mol cell-1 s-1 
x radial distance of CPB lumen thickness m 
z 
z1 
z2 
axial distance 
scaffold bottom to the STB vessel bottom distance 
thickness of STB scaffold construct 
m 
m 
m 
Greek Letters   
α hindrance factor in membrane wall dimensionless 
β hindrance factor in extracapillary space (ECS) dimensionless 
η fluid dynamic viscosity kg m-1 s-1 
ρ fluid density kg m-3 
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Abbreviations   
BC boundary condition - 
BTE bone tissue engineering - 
CPB confined perfused bioreactor - 
DOF degree of freedom - 
ECS extracapillary space - 
FEM finite element method - 
HF hollow fiber - 
HFMB hollow fiber membrane bioreactor - 
NS Navier-Stokes  - 
PDE partial differential equation - 
STB suspended tube bioreactor - 
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Tables 
 
Table 1-Operating parameters used for simulation of nutrient transport behaviour in hollow 
fiber membrane bioreactor (HFMB), confined perfused bioreactor (CPB) and suspended tube 
bioreactor (STB). 
 
 
  
 
 
 
 
 
 
 
 
 
 
Parameter Symbol Unit Value References 
Glucose 
diffusivity  
HFMB lumen 
CPB lumen 
STB vessel 
D1 
D4 
D7 
m2 s-1 5.4×10-10 
Membrane αHFMB = D1/D2 αCPB      = D4/D5 - 10 Hindering 
factors 
ECS 
βHFMB = D1/D3 
βCPB   = D4/D6 
βSTB   = D7/D8 
- 5 
Medium flowrate for HFMB and 
CPB u m s
-1 7.45×10-3   
Cell seeding density d cells m-3 2×1012 
Cell metabolic rate for glucose V mol cell-1 3.83×10-16  
Inlet glucose concentration for 
HFMB and CPB / Glucose 
concentration in STB vessel 
c0 mol m-3 5.55 
L1 0.03  
R1 1.0×10-4  
R2 1.2×10-4  
Krogh cylinder 
in HFMB 
(Figure 3) 
R3 3.2×10-4  
Abdullah et al. (2006); 
Abdullah and Das 
(2007); 
Ye et al. (2006) 
L2 0.01  
x 1.0×10-3  
R4 2.0×10-3  
R5 2.02×10-3  
CPB 
(Figure 2) 
R6 3.02×10-3  
- 
L3 0.0326 
R7 0.01 
R8 5.0×10-3 
z1 0.0148  
Domain 
dimensions 
STB 
(Figure 1) 
z2 
m 
3.0×10-3  
Sengers et al. (2005) 
Water density at 310K ρ kg m-3 993.37 
Water dynamic fluid viscosity at 
310K μ kg m
-1 s-1 0.000692 Ma et al. (2007) 
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Figure 1- Schematic diagram of the suspended tube bioreactor (STB) is on the left. On the 
right are domains defined for nutrient transport modelling in suspended tube bioreactor. The 
defined domains are C1- nutrient solution which is placed in the bioreactor vessel and C2-
suspended scaffold construct (with bone cells) respectively. Please refer Table 1 for 
dimensions. 
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Figure 2- Schematic diagram of the confined perfused bioreactor (CPB) is on the left. On the 
right are domains defined for nutrient transport modelling in the confined perfused bioreactor. 
The defined domains are B1-lumen, B2-membrane wall and B3-scaffold construct (with bone 
cells) respectively. Please refer Table 1 for dimensions. 
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Figure 3- Schematic diagram of a single two dimensional axisymmetrical Krogh cylinder on 
an is on the top. Below the schematic are domains defined for nutrient transport modelling 
(via Krogh cylinder approximation) in the hollow fiber membrane bioreactor (HFMB). Three 
domains are defined, namely A1-fiber lumen, A2-membrane wall and A3-extracapillary space 
(ECS). Please refer Table 1 for dimensions. 
 
 
 
 
 
 
 
 
 
R1 
R2 
R3 
Uy 
A
1 
A
2 
A
3 
Lumen 
Membrane Wall
Extracapillary Space (ECS) 
z 
r 
Fiber length, L1 
Direction of 
nutrient flow 
R1 
R2 
R3 
 34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- Fluid flow and mass transfer characteristics for hollow fiber membrane bioreactor 
(HFMB).  
(a) Profile of velocity field and concentration flux in the lumen region.  
(b) Diffusive flux through the membrane and extracapillary space (ECS) region.  
(c) Pressure distribution near the inlet of the lumen (Pa).  
(d) Pressure distribution near the outlet of lumen region (Pa).  
Characteristics are based on a simulation run for glucose. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) (c) (d) 
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Figure 5- Fluid flow and mass transfer characteristics for confined perfused bioreactor (CPB).  
(a) Profile of velocity field and concentration flux in the lumen.  
(b) Diffusive flux through the membrane region. 
(c) Diffusive flux through the scaffold region. 
(d) Pressure distribution in the lumen (Pa).  
Characteristics are based on a simulation run for glucose. 
 
(a) (b) 
(c) (d) 
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Figure 6- Mass transfer characteristics for suspended tube bioreactor (STB). Arrows in this 
figure represents flux through the bioreactor.  
Characteristics are based on a simulation run for glucose. 
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Figure 7- Profiles of axial and radial glucose concentration (mol m-3) in the extracapillary space 
(ECS) of the hollow fiber membrane bioreactor (HFMB) under control parameters (Refer to Table 
1). Axial profiles are displayed at r = 1.2×10-4m (membrane boundary), r = 2.2×10-4m (centre line 
of extracapillary space) and r = 3.2×10-4m (Krogh cylinder radius). Radial profiles are displayed 
at z/l = 0 (Extracapillary space boundary adjacent to the bioreactor inlet), z/l = 0.5 (middle of 
extracapillary space), z/l = 1 (Extracapillary space boundary at outlet of the bioreactor). 
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Figure 8- Profiles of axial and radial glucose concentration (mol m-3) in the scaffold construct of 
the confined perfused bioreactor (CPB) under control parameters (Refer to Table 1). The axial 
profile is displayed at r = 0 m (central axis of the bioreactor). The radial profile is displayed at z = 
0.005m (centre of the bioreactor, z/l = 0.5). 
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Figure 9- Profiles of axial and radial glucose concentration (mol m-3) in the scaffold of the 
suspended tube bioreactor (STB) under control parameters (Refer to Table 1). The axial profiles is 
displayed at r = 0 m (central axis of the bioreactor). The radial profile is displayed at z = 0.0163m 
(centre of the bioreactor, z/l = 0.5). (‘-ve’ concentration values imply the amount of glucose 
deprived from the cells in the scaffold domain). 
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Figure 10- Radial glucose concentration profiles (mol m-3) in the extracapillary space (ECS) of 
the hollow fiber membrane bioreactor (HFMB) for various inlet glucose concentrations (c0). 
Symbol ‘*’ denotes control value of inlet glucose concentration. 
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Figure 11- Axial glucose concentration profiles (mol m-3) in the scaffold construct of the 
confined perfused bioreactor (CPB) for various inlet glucose concentrations (c0). Symbol ‘*’ 
denotes control value of inlet glucose concentration. 
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Figure 12- Radial glucose concentration profiles (mol m-3) in the extracapillary space (ECS) of 
the hollow fiber membrane bioreactor (HFMB) for various inlet velocities (ms-1). Symbol ‘*’ 
denotes control value of inlet velocity. 
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Figure 13- Axial glucose concentration profiles (mol m-3) in the scaffold of the confined perfused 
bioreactor (CPB) for various inlet velocities (ms-1). Symbol ‘*’ denotes control value of inlet 
velocity. 
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Figure 14- Radial glucose concentration profiles (mol m-3) in the extracapillary space (ECS) of 
the hollow fiber membrane bioreactor (HFMB) for various cell densities (cells m-3). Symbol ‘*’ 
denotes control value of cell density. 
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Figure 15- Axial glucose concentration profiles (mol m-3) in the scaffold of the confined perfused 
bioreactor (CPB) for various cell densities (cells m-3). Symbol ‘*’ denotes control value of cell 
density. (‘-ve’ concentration values imply the amount of glucose deprived from the cells in the 
scaffold domain). 
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Figure 16- Radial glucose concentration profiles (mol m-3) in the extracapillary space (ECS) of 
the hollow fiber membrane bioreactor (HFMB) for various scaffold hindering factors (β). Symbol 
‘*’ denotes control value of hindering factor (β=5). 
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Figure 17- Axial glucose concentration profiles (mol m-3) in the scaffold construct of the confined 
perfused bioreactor (CPB) for various scaffold hindering factors (β). Symbol ‘*’ denotes control 
value of hindering factor (β=5). (‘-ve’ concentration values imply the amount of glucose deprived 
from the cells in the scaffold domain). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
